Global RNAi for Therapeutic Market Research Report 2012-2024
SUMMARY
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
The global RNAi for Therapeutic market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
The global RNAi for Therapeutic market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
- siRNA
- miRNA
- shRNA
- Alnylam Pharmaceuticals
- Arrowhead
- Dicerna Pharmaceuticals
- Mirna Therapeutics
- Quark Pharmaceuticals
- RXi Pharmaceuticals
- miRagen Therapeutics
- Gradalis
- Sirnaomics
- Cancer
- Cardiovascular
- HBV
- Others
- Asia-Pacific
- North America
- Europe
- South America
- Middle East & Africa
1 MARKET OVERVIEW
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 siRNA
1.2.1.2 miRNA
1.2.1.3 shRNA
1.2.2 by Application
1.2.2.1 Cancer
1.2.2.2 Cardiovascular
1.2.2.3 HBV
1.2.2.4 Others
1.2.3 by Regions
2 INDUSTRY CHAIN
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 ENVIRONMENTAL ANALYSIS
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 MARKET SEGMENTATION BY TYPE
4.1 Market Size
4.1.1 siRNA Market, 2013-2018
4.1.2 miRNA Market, 2013-2018
4.1.3 shRNA Market, 2013-2018
4.2 Market Forecast
4.2.1 siRNA Market Forecast, 2019-2024
4.2.2 miRNA Market Forecast, 2019-2024
4.2.3 shRNA Market Forecast, 2019-2024
5 MARKET SEGMENTATION BY APPLICATION
5.1 Market Size
5.1.1 Cancer Market, 2013-2018
5.1.2 Cardiovascular Market, 2013-2018
5.1.3 HBV Market, 2013-2018
5.1.4 Others Market, 2013-2018
5.2 Market Forecast
5.2.1 Cancer Market Forecast, 2019-2024
5.2.2 Cardiovascular Market Forecast, 2019-2024
5.2.3 HBV Market Forecast, 2019-2024
5.2.4 Others Market Forecast, 2019-2024
6 MARKET SEGMENTATION BY REGION
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 MARKET COMPETITIVE
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 MAJOR VENDORS
8.1 Alnylam Pharmaceuticals
8.2 Arrowhead
8.3 Dicerna Pharmaceuticals
8.4 Mirna Therapeutics
8.5 Quark Pharmaceuticals
8.6 RXi Pharmaceuticals
8.7 miRagen Therapeutics
8.8 Gradalis
8.9 Sirnaomics
9 CONCLUSION
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 siRNA
1.2.1.2 miRNA
1.2.1.3 shRNA
1.2.2 by Application
1.2.2.1 Cancer
1.2.2.2 Cardiovascular
1.2.2.3 HBV
1.2.2.4 Others
1.2.3 by Regions
2 INDUSTRY CHAIN
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 ENVIRONMENTAL ANALYSIS
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 MARKET SEGMENTATION BY TYPE
4.1 Market Size
4.1.1 siRNA Market, 2013-2018
4.1.2 miRNA Market, 2013-2018
4.1.3 shRNA Market, 2013-2018
4.2 Market Forecast
4.2.1 siRNA Market Forecast, 2019-2024
4.2.2 miRNA Market Forecast, 2019-2024
4.2.3 shRNA Market Forecast, 2019-2024
5 MARKET SEGMENTATION BY APPLICATION
5.1 Market Size
5.1.1 Cancer Market, 2013-2018
5.1.2 Cardiovascular Market, 2013-2018
5.1.3 HBV Market, 2013-2018
5.1.4 Others Market, 2013-2018
5.2 Market Forecast
5.2.1 Cancer Market Forecast, 2019-2024
5.2.2 Cardiovascular Market Forecast, 2019-2024
5.2.3 HBV Market Forecast, 2019-2024
5.2.4 Others Market Forecast, 2019-2024
6 MARKET SEGMENTATION BY REGION
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 MARKET COMPETITIVE
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 MAJOR VENDORS
8.1 Alnylam Pharmaceuticals
8.2 Arrowhead
8.3 Dicerna Pharmaceuticals
8.4 Mirna Therapeutics
8.5 Quark Pharmaceuticals
8.6 RXi Pharmaceuticals
8.7 miRagen Therapeutics
8.8 Gradalis
8.9 Sirnaomics
9 CONCLUSION
LIST OF TABLES
Table Product Specifications of RNAi for Therapeutic
Table Products Segment of RNAi for Therapeutic
Table siRNA Overview
Table miRNA Overview
Table shRNA Overview
Table Global RNAi for Therapeutic Market by Type, 2011-2022 (USD Million)
Table Application Segment of RNAi for Therapeutic
Table Cancer Overview
Table Cardiovascular Overview
Table HBV Overview
Table Others Overview
Table Global RNAi for Therapeutic Market by Application, 2011-2022 (USD Million)
Table Global RNAi for Therapeutic Market by Region, 2011-2022 (USD Million)
Table Cost of RNAi for Therapeutic
Table Market Dynamics
Table Policy of RNAi for Therapeutic
Table GDP of Major Countries
Table siRNA CAGR by Revenue and Volume, 2012-2018
Table miRNA CAGR by Revenue and Volume, 2012-2018
Table shRNA CAGR by Revenue and Volume, 2012-2018
Table siRNA CAGR by Revenue and Volume, 2012-2024
Table miRNA CAGR by Revenue and Volume, 2012-2024
Table shRNA CAGR by Revenue and Volume, 2012-2024
Table Cancer CAGR by Revenue and Volume, 2012-2018
Table Cardiovascular CAGR by Revenue and Volume, 2012-2018
Table HBV CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Global RNAi for Therapeutic Market by Vendors, 2012-2018 (USD Million)
Table Global RNAi for Therapeutic Market by Vendors, 2012-2018 (in Volume)
Table Global RNAi for Therapeutic Market Share by Vendors, 2012-2018 (USD Million)
Table Global RNAi for Therapeutic Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Alnylam Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Alnylam Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Arrowhead Profile List
Table Microecological Modulator Operating Data of Arrowhead (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dicerna Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Dicerna Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mirna Therapeutics Profile List
Table Microecological Modulator Operating Data of Mirna Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Quark Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Quark Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table RXi Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of RXi Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table miRagen Therapeutics Profile List
Table Microecological Modulator Operating Data of miRagen Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gradalis Profile List
Table Microecological Modulator Operating Data of Gradalis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sirnaomics Profile List
Table Microecological Modulator Operating Data of Sirnaomics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Product Specifications of RNAi for Therapeutic
Table Products Segment of RNAi for Therapeutic
Table siRNA Overview
Table miRNA Overview
Table shRNA Overview
Table Global RNAi for Therapeutic Market by Type, 2011-2022 (USD Million)
Table Application Segment of RNAi for Therapeutic
Table Cancer Overview
Table Cardiovascular Overview
Table HBV Overview
Table Others Overview
Table Global RNAi for Therapeutic Market by Application, 2011-2022 (USD Million)
Table Global RNAi for Therapeutic Market by Region, 2011-2022 (USD Million)
Table Cost of RNAi for Therapeutic
Table Market Dynamics
Table Policy of RNAi for Therapeutic
Table GDP of Major Countries
Table siRNA CAGR by Revenue and Volume, 2012-2018
Table miRNA CAGR by Revenue and Volume, 2012-2018
Table shRNA CAGR by Revenue and Volume, 2012-2018
Table siRNA CAGR by Revenue and Volume, 2012-2024
Table miRNA CAGR by Revenue and Volume, 2012-2024
Table shRNA CAGR by Revenue and Volume, 2012-2024
Table Cancer CAGR by Revenue and Volume, 2012-2018
Table Cardiovascular CAGR by Revenue and Volume, 2012-2018
Table HBV CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Global RNAi for Therapeutic Market by Vendors, 2012-2018 (USD Million)
Table Global RNAi for Therapeutic Market by Vendors, 2012-2018 (in Volume)
Table Global RNAi for Therapeutic Market Share by Vendors, 2012-2018 (USD Million)
Table Global RNAi for Therapeutic Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Alnylam Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Alnylam Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Arrowhead Profile List
Table Microecological Modulator Operating Data of Arrowhead (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dicerna Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Dicerna Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mirna Therapeutics Profile List
Table Microecological Modulator Operating Data of Mirna Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Quark Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Quark Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table RXi Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of RXi Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table miRagen Therapeutics Profile List
Table Microecological Modulator Operating Data of miRagen Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gradalis Profile List
Table Microecological Modulator Operating Data of Gradalis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sirnaomics Profile List
Table Microecological Modulator Operating Data of Sirnaomics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
LIST OF FIGURES
Figure RNAi for Therapeutic Picture
Figure Industry Chain Structure of RNAi for Therapeutic
Figure SWOT of RNAi for Therapeutic
Figure siRNA Market Size and Growth, 2012-2018 (USD Million)
Figure siRNA Market Size and Growth, 2012-2018 (in Volume)
Figure miRNA Market Size and Growth, 2012-2018 (USD Million)
Figure miRNA Market Size and Growth, 2012-2018 (in Volume)
Figure shRNA Market Size and Growth, 2012-2018 (USD Million)
Figure shRNA Market Size and Growth, 2012-2018 (in Volume)
Figure siRNA Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure siRNA Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure miRNA Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure miRNA Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure shRNA Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure shRNA Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Cancer Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Cardiovascular Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure HBV Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure RNAi for Therapeutic Market Concentration by Region
Figure Marketing Channels Overview
Figure RNAi for Therapeutic Picture
Figure Industry Chain Structure of RNAi for Therapeutic
Figure SWOT of RNAi for Therapeutic
Figure siRNA Market Size and Growth, 2012-2018 (USD Million)
Figure siRNA Market Size and Growth, 2012-2018 (in Volume)
Figure miRNA Market Size and Growth, 2012-2018 (USD Million)
Figure miRNA Market Size and Growth, 2012-2018 (in Volume)
Figure shRNA Market Size and Growth, 2012-2018 (USD Million)
Figure shRNA Market Size and Growth, 2012-2018 (in Volume)
Figure siRNA Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure siRNA Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure miRNA Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure miRNA Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure shRNA Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure shRNA Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Cancer Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Cardiovascular Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure HBV Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure RNAi for Therapeutic Market Concentration by Region
Figure Marketing Channels Overview
